Kevin T Nguyen, Nicole Y Xu, Jennifer Y Zhang, Trisha Shang, Ananda Basu, Richard M Bergenstal, Kristin Castorino, Kong Y Chen, David Kerr, Suneil K Koliwad, Lori M Laffel, Nestoras Mathioudakis, L Kurt Midyett, Joshua D Miller, James H Nichols, Francisco J Pasquel, Priya Prahalad, Mark R Prausnitz, Jane Jeffrie Seley, Jennifer L Sherr, Elias K Spanakis, Guillermo E Umpierrez, Amisha Wallia, David C Klonoff
This article is the work product of the Continuous Ketone Monitoring Consensus Panel, which was organized by Diabetes Technology Society and met virtually on April 20, 2021. The panel consisted of 20 US-based experts in the use of diabetes technology, representing adult endocrinology, pediatric endocrinology, advanced practice nursing, diabetes care and education, clinical chemistry, and bioengineering. The panelists were from universities, hospitals, freestanding research institutes, government, and private practice...
October 4, 2021: Journal of Diabetes Science and Technology